[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100125345":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":22,"responsibleParty":39,"collaborators":10,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":10,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"University of California, Davis","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with lung cancer",null,"Collection of archival tumor specimen at the beginning of the study and collection of blood samples at the beginning of the study and then at regular intervals",[13],{"name":14,"affiliation":5,"role":15},"Jonathan Riess, MD","PRINCIPAL_INVESTIGATOR",[17],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Office of Clinical Research","CONTACT","916-382-6970","OCRReferral@health.ucdavis.edu",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"University of California Davis Cancer Center","RECRUITING","Sacramento","California","95817","United States","US",{"type":32,"coordinates":33},"Point",[34,35],-121.4944,38.58157,{"lat":35,"lon":34},[38],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100125345","studying-tumor-tissue-samples-and-blood-samples-to-learn-more-about-dna-changes-in-patients-with-lung-cancer-100125345",false,"NCT00899405","Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer","EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood","DISEASE CHARACTERISTICS:\n\n* Histologically or cytologically confirmed lung cancer\n\nPATIENT CHARACTERISTICS:\n\n* Not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* May have received prior EGFR inhibitors","ALL","18 Years",{"count":51,"type":52},800,"ESTIMATED","OBSERVATIONAL","RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.\n\nPURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.",[56],"Lung Cancer",[58],"lung cancer","2026-06-22",{"date":61,"type":62},"2026-06-25","ACTUAL",{"date":64,"type":62},"2004-05-19",{"date":66,"type":52},"2034-05",{"name":5,"class":6},1]